'There is a very real impact on Australian patients and clinicians'

Lilly General Manager Tori Brown said, “The Government has acknowledged patients face delays in accessing PBS-reimbursed treatments. Now, more than ever, HTA reform must be a key priority – without it, Australians will continue to miss out on the world’s latest medicines.” …